首页> 外文OA文献 >A novel method for the synthesis of Indolo2,1-aisoquinolines and modelling studies of 3-substituted oxindoles against PfPK5
【2h】

A novel method for the synthesis of Indolo2,1-aisoquinolines and modelling studies of 3-substituted oxindoles against PfPK5

机译:吲哚2,1-a异喹啉合成的新方法和针对PfPK5的3-取代的吲哚的模型研究

摘要

Many naturally occurring and synthetically made azapolycyclic aromatic ringudsystems display important biological activities. One class of naturally occurringudazapolycyclic aromatic ring systems is the dibenzopyrrocoline alkaloids, madeudfrom an indole nucleus fused to an isoquinoline system sharing the sameudnitrogen, i.e. the indolo[2,1-a]isoquinoline nucleus. The indolo[2,1-a]isoquinolineudand its analogues have been reported to possess antileukemic, tubulinudpolymerization inhibitory and antitumor activity.udA variety of indolo[2,1-a]isoquinolines have been synthesized in our labs. Thisudincludes, the 5,12-dimethyl-6-phenylindolo[2,1-a]isoquinoline, using the Suzuki-udMiyaura cross-coupling reaction and reaction conditions for the formation ofudaromatic rings (KOBut in DMF) developed in our laboratories. In this dissertation,udwe outline the syntheses of (±)-5,6-dihydro-6-phenylindolo[2,1-a]isoquinolin-5-oludand 2-(1-benzyl-1H-benzo[d]imidazol-2-yl)benzaldehyde. We also discuss theudsynthesis and the modelling studies, (docked in silico) of the 3-substitutedudoxindoles in the X-ray crystal structure of the PfPK5 cyclin dependent kinaseud(CDK).udThe synthesis of indolo[2,1-a]isoquinolines started with N-protection of isatin andudbenzimidazole with a benzyl group to afford 1-benzylindoline-2,3-dione and 1-udbenzyl-1H-benzo[d]imidazole, respectively. The next step was the synthesis ofudthe brominated compound, 1-benzyl-2-bromo-1H-indole, and the iodatedudcompound, 1-benzyl-2-iodo-1H-benzo[d]imidazole. 1-Benzyl-2-bromo-1H-indoleudwas synthesized by means of a functional group interconversion of the oxygen inudthe 3-position of isatin to two chlorine atoms initially, followed by removal of thoseudchlorine atoms with activated zinc, followed by the conversion of the carbonyl ofudthe oxindole to give a 2-bromoindole using POBr3. 1-Benzyl-2-iodo-1Hbenzo[udd]imidazole was synthesized in two ways. Firstly, 1-benzyl-1Hbenzo[udd]imidazole was exposed to LDA followed by iodinating the 2-position byud5udexposure of the intermediate to diiodoethane. The second method uses audhalogenating method developed in our labs. 1-Benzyl-1H-benzo[d]imidazole wasudexposed to isopropylmagnesium chloride lithium chloride followed by I2. Havingudobtained the halogenated products, both sets of halogenated precursors wereudcoupled with 2-formylphenylboronic acid using the Suzuki-Miyaura crosscouplingudreaction to obtain the products, 2-(1-benzyl-1H-indol-2-yl)benzaldehydeudand 2-(1-benzyl-1H-benzo[d]imidazol-2-yl)benzaldehyde in 98 and 67% yield,udrespectively. Aromatization of 2-(1-benzyl-1H-indol-2-yl)benzaldehyde occurredudeasily using tBuOK in DMF at room temperature to afford (±)-5,6-dihydro-6-udphenylindolo[2,1-a]isoquinolin-5-ol in 75% yield (7:3 ratio of anti-: syn-) butudexposing 2-(1-benzyl-1H-benzo[d]imidazol-2-yl)benzaldehyde to the sameudreaction conditions did not afford the desired product. Dehydrating (±)-5,6-uddihydro-6-phenylindolo[2,1-a]isoquinolin-5-ol using methanesulfonyl chloride inudCH2Cl2 was unsuccessful. Further attempts at dehydrating (±)-5,6-dihydro-6-udphenylindolo[2,1-a]isoquinolin-5-ol were prevented due to time constraints.udIn the last part of the project, a library of 3-substituted oxindoles (13 molecules)udwas synthesized successfully and the compounds were docked in silico in theudactive site of an X-ray crystal structure of PfPK5, a cyclin dependent kinase ofudthe Plasmodium falciparum, the agent causing the most severe form of humanudmalaria. Eleven of the thirteen compounds were synthesized by condensation ofudoxindole and a suitable aldehyde in the presence of piperidine. The other two, 3-ud(propan-2-ylidene)indolin-2-one and 5,6-dimethoxy-3-(methylthio)indolin-2-one,udwere synthesized differently. 3-(Propan-2-ylidene)indolin-2-one was synthesizedudby reacting the oxindole with acetone in the presence of HCl and 5,6-dimethoxy-ud3-(methylthio)indolin-2-one was synthesized following Gassman’s methodology.udTwo molecules scored well in the molecular modelling studies using the X-rayudcrystal structure of PfPK5, namely, (E/Z)-3-(3,4-dimethoxybenzylidene)indolin-2-udone and (Z)-3-(4-hydroxybenzylidene)indolin-2-one.ud6udIn conclusion, we managed to synthesize (±)-5,6-dihydro-6-phenylindolo[2,1-uda]isoquinolin-5-ol using the Suzuki Miyaura cross-coupling reaction and reactionudconditions that lead to aromatization (tBuOK in DMF at room temperature) as keyudsteps and 2-(1-benzyl-1H-benzo[d]imidazol-2-yl)benzaldehyde using the Suzuki-udMiyaura cross-coupling reaction. A library of 3-substituted oxindoles was madeudand using molecular modelling were docked in silico into the crystal structure ofudthe active site of PfPK5 with 2 compounds showing promise, for further studies.
机译:许多天然存在的和人工合成的氮杂多环芳环系统显示出重要的生物学活性。一类天然存在的uda多氮杂多环芳环系统是二吲哚并吡咯啉碱生物碱,其由与共享相同氮的异喹啉体系即吲哚[2,1-a]异喹啉核融合的吲哚核制成。吲哚[2,1-a]异喹啉及其类似物据报道具有抗白血病,微管蛋白 udpolymerization抑制和抗肿瘤活性。 ud我们实验室已经合成了多种吲哚[2,1-a]异喹啉。这包括5,12-二甲基-6-苯基吲哚并[2,1-a]异喹啉,它使用Suzuki- udMiyaura交叉偶联反应和形成conditions环的反应条件(KOBut in DMF)开发,我们的实验室。在本文中, udwe概述了(±)-5,6-二氢-6-苯基吲哚[2,1-a]异喹啉-5-醇的合成及2-(1-苄基-1H-苯并[d]的合成咪唑-2-基)苯甲醛。我们还讨论了PfPK5细胞周期蛋白依赖性激酶Xud的X射线晶体结构中3-取代的 udoxindoles的 udsynthesis和建模研究(通过计算机模拟)。 udindolo [2, 1-a]异喹啉开始于用苄基对Isatin和 udbenzimidazole进行N-保护,分别得到1-苄基吲哚啉-2,3-二酮和1- ud苄基-1H-苯并[d]咪唑。下一步是合成溴化的化合物1-苄基-2-溴-1H-吲哚和碘化的化合物1-苄基-2-碘-1H-苯并[d]咪唑。首先通过将isatin的3位上的氧转变为两个氯原子,然后用活化的锌除去那些 udchlorine原子,然后将其官能团相互转化,从而合成1-Benzyl-2-bromo-1H-吲哚 ud然后使用POBr3将吲哚的羰基转化为2-溴吲哚。 1-苄基-2-碘-1H苯并[咪唑]咪唑的合成方法有两种。首先,将1-苄基-1H苯并[咪唑]咪唑暴露于LDA,然后通过将中间体中间体二碘乙烷暴露于碘来碘化2-位。第二种方法使用在我们的实验室中开发的 udhalogenisation方法。将1-苄基-1H-苯并[d]咪唑在异丙基氯化镁氯化锂中脱甲苯,然后在I2中。 获得了卤化产物后,使用Suzuki-Miyaura交联偶合反应,将两组卤化前体与2-甲酰基苯基硼酸偶联得到产物2-(1-苄基-1H-吲哚-2-基)苯甲醛分别以98和67%的产率得到双(2-)-(1-苄基-1H-苯并[d]咪唑-2-基)苯甲醛。在室温下使用tBuOK在DMF中轻松进行2-(1-苄基-1H-吲哚-2-基)苯甲醛的芳香化反应,得到(±)-5,6-dihydro-6- udphenylindolo [2,1-a ]异喹啉-5-醇,产率为75%(抗-:顺-的比例为7:3),但是将2-(1-苄基-1H-苯并[d]咪唑-2-基)苯甲醛去异化分解条件不能提供所需的产品。使用 udCH2Cl2中的甲磺酰氯将(±)-5,6- uddihydro-6-phenylindolo [2,1-a] isoquinolin-5-ol脱水失败。由于时间限制,阻止了进一步脱水(±)-5,6-二氢-6- udphenylindolo [2,1-a] isoquinolin-5-ol的尝试。 ud在该项目的最后一部分,一个3个库已成功合成了取代的羟吲哚(13个分子),并将这些化合物在计算机上停泊在恶性疟原虫恶性疟原虫(一种引起最严重形式的药剂)的细胞周期蛋白依赖性激酶PfPK5的X射线晶体结构的放射性位点中人类 udmalaria。在哌啶的存在下,udo /吲哚和合适的醛缩合合成了13种化合物中的11种。其他两个3- ud(丙烷-2-亚烷基)吲哚-2-酮和5,6-二甲氧基-3-(甲硫基)吲哚-2-酮以不同的方式合成。通过在盐酸存在下使吲哚与丙酮反应合成3-(丙-2-亚烷基)吲哚-2-酮,然后按照加斯曼法合成5,6-二甲氧基-ud3-(甲硫基)吲哚-2-酮。 ud使用PfPK5的X射线 ud晶体结构在分子建模研究中获得了良好的评价,即(E / Z)-3-(3,4-二甲氧基亚苄基)indolin-2- udone和(Z) -3-(4-羟基亚苄基)吲哚-2-酮。 ud6 ud最后,我们设法合成了(±)-5,6-dihydro-6-phenylindolo [2,1- uda] isoquinolin-5-ol使用Suzuki Miyaura交叉偶联反应和导致芳香化的反应/条件(室温DMF中的tBuOK在室温下)作为关键步骤,并使用2-(1-苄基-1H-苯并[d]咪唑-2-基)苯甲醛Suzuki- udMiyaura交叉偶联反应。制备了3-取代的羟吲哚的文库,并使用分子模型将其在计算机上对接至PfPK5的活性位点的晶体结构中,其中有两种化合物显示出希望,尚待进一步研究。

著录项

  • 作者

    Sello Thato Saoeni;

  • 作者单位
  • 年度 2008
  • 总页数
  • 原文格式 PDF
  • 正文语种 en
  • 中图分类

相似文献

  • 外文文献
  • 中文文献
  • 专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号